Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma
Clare E Weeden, Aliaksei Z Holik, Richard J Young, Stephen B Ma, Jean-Marc Garnier, Stephen B Fox, Phillip Antippa, Louis B Irving, Daniel P Steinfort, Gavin M Wright, Prudence A Russell, Matthew E Ritchie, Christopher J Burns, Benjamin Solomon, Marie-Liesse Asselin-Labat
Molecular Cancer Therapeutics | AMER ASSOC CANCER RESEARCH | Published : 2017
M.-L. Asselin-Labat is supported by a Viertel Foundation Senior Medical Researcher Fellowship. C.E. Weeden is supported by an Australian Post-Graduate Award and a Cancer Therapeutics CRC Top-Up Scholarship. This work was supported by grants from the Victorian Cancer Agency, the Cancer Therapeutics CRC, the Harry Secomb Foundation, the Ian Potter Foundation, the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.